Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,406 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical effects of COX-2 inhibitors on cognition in schizophrenia.
Müller N, Riedel M, Schwarz MJ, Engel RR. Müller N, et al. Eur Arch Psychiatry Clin Neurosci. 2005 Apr;255(2):149-51. doi: 10.1007/s00406-004-0548-4. Epub 2004 Nov 19. Eur Arch Psychiatry Clin Neurosci. 2005. PMID: 15549344 Clinical Trial.
Anti-inflammatory treatment in schizophrenia.
Müller N, Myint AM, Krause D, Weidinger E, Schwarz MJ. Müller N, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2013 Apr 5;42:146-53. doi: 10.1016/j.pnpbp.2012.11.008. Epub 2012 Nov 23. Prog Neuropsychopharmacol Biol Psychiatry. 2013. PMID: 23178230 Review.
Low-Grade Inflammation as a Predictor of Antidepressant and Anti-Inflammatory Therapy Response in MDD Patients: A Systematic Review of the Literature in Combination With an Analysis of Experimental Data Collected in the EU-MOODINFLAME Consortium.
Arteaga-Henríquez G, Simon MS, Burger B, Weidinger E, Wijkhuijs A, Arolt V, Birkenhager TK, Musil R, Müller N, Drexhage HA. Arteaga-Henríquez G, et al. Among authors: muller n. Front Psychiatry. 2019 Jul 9;10:458. doi: 10.3389/fpsyt.2019.00458. eCollection 2019. Front Psychiatry. 2019. PMID: 31354538 Free PMC article.
Efficacy of Sertraline Plus Placebo or Add-On Celecoxib in Major Depressive Disorder: Macrophage Migration Inhibitory Factor as a Promising Biomarker for Remission After Sertraline-Results From a Randomized Controlled Clinical Trial.
Simon MS, Burger B, Weidinger E, Arteaga-Henríquez G, Zill P, Musil R, Drexhage HA, Müller N. Simon MS, et al. Among authors: muller n. Front Psychiatry. 2021 Sep 27;12:615261. doi: 10.3389/fpsyt.2021.615261. eCollection 2021. Front Psychiatry. 2021. PMID: 34646168 Free PMC article.
2,406 results